Holdings
Enavate Sciences Gp, LLC
As of Jun 30, 2026, Enavate Sciences Gp, LLC reported 7 positions worth US$345M. Largest: Sionna Therapeutics, Inc., Zenas Biopharma, Inc. and Immunome, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Sionna Therapeutics, Inc. | 2.48M | US$109M | no change | Jun 30, 2026 |
| Zenas Biopharma, Inc. | 3.92M | US$99.5M | no change | Jun 30, 2026 |
| Immunome, Inc. | 3.61M | US$76.6M | no change | Jun 30, 2026 |
| Bridgebio Oncology Therapeutics, Inc. | 2.63M | US$20M | no change | Jun 30, 2026 |
| Compass Therapeutics, Inc. | 7.79M | US$17.1M | no change | Jun 30, 2026 |
| Upstream Bio, Inc. | 2.46M | US$17M | no change | Jun 30, 2026 |
| Camp4 Therapeutics Corporation | 1.43M | US$6.23M | −765K | Jun 30, 2026 |